Loading Events

« All Events

  • This event has passed.

Mainstreaming Genomic Medicine: Breast Cancer

January 24 2022 @ 1:00 PM - 2:00 PM

|Recurring Event (See all)

One event on April 21 2022 at 1:00 PM

Part of an online series of interactive workshops organised by the team at North Thames GMSA/GLH, with the aim to provide healthcare professionals the opportunities to engage and ask questions and find out what further information and support is available.

Breast Cancer

This specialist session will focus on the practical application of genomics in Breast Cancer.

Mon 24th Jan 2022 13.00-14.00 or Thu 21st Apr 2022 13.00-14.00


To book your place and if you have any questions, would like further information or to discuss individual needs, please contact the Programme Lead Corrine Trim on corinnetrim@nhs.net.


The programme has been developed in the line with the HEE GEP competency framework to facilitate the consent conversation for genomic testing and the competency framework for communicating germline genomic results.

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.